新型人兽共患多重耐药猪链球菌谱系的出现
该研究对141株泰国猪链球菌(人兽共患与猪源)进行全基因组测序,并结合全球2761株公开基因组,用比较基因组学与贝叶斯进化模型分析CC104和CC233谱系的出现与近期演化。两谱系分别估计出现于1990年和2002年,均通过荚膜位点转换从CC1获得血清2型荚膜,并多次获得耐药决定因子,成为首批对青霉素和头孢曲松耐药性增加的人兽共患谱系。
要点
- CC104和CC233是泰国约40%人兽共患猪链球菌感染的流行谱系,均携带血清2型荚膜。
- 两谱系通过荚膜位点转换从CC1获得血清2型荚膜,并多次获得耐药决定因子。
- 部分菌株携带12个耐药决定因子,覆盖8类抗生素,且对青霉素和头孢曲松耐药性增加。
核心结论
- 多位点水平转移可导致新型多重耐药人兽共患猪链球菌谱系快速出现。
- CC104和CC233是首批对青霉素和头孢曲松耐药性增加的人兽共患谱系,而这两药是治疗人猪链球菌感染的标准方案。
研究设计与样本
- 对141株泰国猪链球菌人兽共患与猪源分离株(15年期间)进行全基因组测序,并与2761株全球公开猪链球菌基因组整合。
- 采用比较基因组学、贝叶斯进化模型和多变量分析研究CC104和CC233的人兽共患潜力与多重耐药性的出现。
主要发现
- CC104估计出现于1990年(95%后验区间1987-1992),CC233估计出现于2002年(95%后验区间2000-2004)。
- 两谱系在出现前均通过荚膜位点转换事件从CC1获得血清2型荚膜。
- 两谱系经历多次抗菌药物耐药获得事件,部分菌株携带12个决定因子,编码对8类抗生素的耐药。
- CC104和CC233是首批对青霉素和头孢曲松耐药性增加的人兽共患谱系。
关键数值与推荐
- 泰国约40%报告的人兽共患猪链球菌感染由CC104和CC233两个地方性流行谱系引起,均具有血清2型荚膜。
临床怎么用
- 猪链球菌在猪和人均主要依靠抗生素控制与治疗,需加强监测、感染控制和治疗策略以应对多重耐药人兽共患谱系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Streptococcus suis is an emerging zoonotic porcine pathogen and a leading cause of adult bacterial meningitis in Southeast Asia, associated with raw pork consumption. Most zoonotic S. suis infections globally are caused by strains from lineage CC1 carrying a serotype 2 capsule. However, in Thailand, ∼40% of the reported zoonotic infections are caused by 2 endemic lineages, CC104 and CC233, which also have a serotype 2 capsule. In this study, we aimed to identify the drivers of the emergence and recent evolution of these two lineages. METHODS: We sequenced the whole genomes of 141 Thai S. suis zoonotic and porcine strains isolated over a 15-year period and combined them with a curated global dataset of 2761 published S. suis genomes. Using comparative genomics, Bayesian evolutionary models, and multivariate analysis, we investigated the emergence of zoonotic potential and multidrug resistance in CC104 and CC233. RESULTS: We estimated recent emergence dates for both CC104 (1990; 95% posterior: 1987-1992) and CC233 (2002; 95% posterior: 2000-2004). Both lineages acquired a serotype capsule 2 from CC1 through a capsule locus switching event, prior to their emergence. Both lineages have also experienced multiple antimicrobial resistance acquisition events, with some strains carrying 12 determinants encoding resistance against 8 classes of antibiotics. Most importantly, CC104 and CC233 lineages are the first zoonotic lineages to have acquired increased resistance to penicillin and ceftriaxone, which form the standard therapy to treat S. suis infections in humans. CONCLUSIONS: Horizontal transfer of multiple genomic regions can cause rapid emergence of novel multidrug-resistant zoonotic S. suis lineages. As S. suis is mainly controlled and treated through the use of antibiotics in both pigs and humans, these findings highlight the urgent need for improved and enhanced surveillance, infection control, and treatments.
引用
- Brizuela J, Murray GGR, Boueroy P, et al. Emergence of novel zoonotic and multidrug-resistant Streptococcus suis lineages. Clin Microbiol Infect. 2026. PMID: 41833604. doi:10.1016/j.cmi.2026.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。